Tuesday, June 26, 2018 7:48:43 AM
Russel
Recent XOMA News
- XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. • GlobeNewswire Inc. • 02/09/2026 02:53:00 PM
- XOMA Royalty Announces CFO Transition • GlobeNewswire Inc. • 01/12/2026 12:30:00 PM
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 12/22/2025 12:30:00 PM
- XOMA Royalty Enters into Agreement to Acquire Generation Bio • GlobeNewswire Inc. • 12/15/2025 10:00:00 PM
- XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc • GlobeNewswire Inc. • 12/05/2025 02:00:00 PM
- Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition • GlobeNewswire Inc. • 12/05/2025 12:45:00 PM
- Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty • GlobeNewswire Inc. • 11/26/2025 02:00:00 PM
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 11/21/2025 12:45:00 PM
- XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 11/12/2025 12:30:00 PM
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline • GlobeNewswire Inc. • 11/10/2025 09:09:25 PM
- Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty • GlobeNewswire Inc. • 10/24/2025 08:25:31 PM
- XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement • GlobeNewswire Inc. • 10/17/2025 03:45:00 PM
- XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 10/02/2025 08:43:26 PM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (US) • 09/24/2025 10:00:00 AM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (Canada) • 09/24/2025 10:00:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 09/22/2025 11:30:00 AM
- XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. • GlobeNewswire Inc. • 09/17/2025 01:00:00 PM
- XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2025 11:30:00 AM
- Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share • GlobeNewswire Inc. • 08/20/2025 12:49:14 PM
- Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share • GlobeNewswire Inc. • 08/20/2025 12:30:00 PM
- XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 08/13/2025 11:30:00 AM
- XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics • GlobeNewswire Inc. • 08/11/2025 01:00:00 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc. • PR Newswire (US) • 08/05/2025 10:01:00 PM
- Hillevax Shares Gain on Acquisition Deal with XOMA Royalty • IH Market News • 08/04/2025 03:00:59 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
